Microarrays in Limbo

The votes are in and it would seem that the research community hasn't quite made up its mind about what to do with microarrays just yet.

In a recent poll conducted by the RNA-Seq Blog, about half of 175 total respondents, or 88 voters, declared that microarrays are here to stay, while the remaining 50 percent, or 87 voters, believe that its time is over.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.